Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments
Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?
Objective: To observe if stimulation of deep brain tissue can improve expression of the mouth in Parkinson's disease patients. Background: Masked facies or hypomimia is…An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator
Objective: To understand changes in patients' desired control of the DBS stimulator in a consecutive series of subjects who underwent DBS for the treatment of…Weight changes in PD patients post-DBS: A look at the factors involved
Objective: To evaluate the factors associated with weight changes in Parkinson's disease (PD) patients after deep brain stimulation (DBS) surgery. Background: DBS is a well-established…Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease
Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes
Objective: To evaluate clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes (T2DM) 1-year after operation due to lower extremity artery disease (LEAD)…Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
Objective: To evaluate the differences in striatal subregional dopamine transporter loss in Parkinson's disease (PD) and supranuclear palsy (PSP) and the diagnostic value of [18F]PR04.MZ…Clinical phenotype (motor and neuropsychological presentation) and neuroimaging in Sardinian patients affected by atypical parkinsonisms, carriers of 20-22 repeats of C9ORF72 hexanucleotide expansion
Objective: Based on our previous finding of the p.A382T of TARDBP in patients with concomitant parkinsonism in the Sardinian population, we hypothesized that also the…Parkinsonism in patients with CADASIL
Objective: To report the clinical manifestation of parkinsonism in patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) confirmed by the NOTCH3…Body weight determinants in Parkinson’s disease: A multifactorial study
Objective: The aim of this study was to investigate the relationship between some of the variables that may influence body weight and the observed body…
- « Previous Page
- 1
- …
- 309
- 310
- 311
- 312
- 313
- …
- 388
- Next Page »